Literature DB >> 3543541

Hormonal replacement therapy: benefits, risks, doses.

L C Huppert.   

Abstract

This chapter presents information on the indications for the use of post menopausal hormone therapy. Side effects and risks of this form of therapy are also summarized. Recommendations are made concerning the clinical management of patients receiving hormone treatment.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3543541     DOI： 10.1016/s0025-7125(16)30880-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  7 in total

Review 1.  A risk-benefit appraisal of transdermal estradiol therapy.

Authors:  A Cheang; R Sitruk-Ware; W H Utian
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 2.  Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

Authors:  J A Balfour; R C Heel
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. II. Pharmacodynamic responses.

Authors:  M H Rahimy; J W Simpkins; N Bodor
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

4.  Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.

Authors:  J Y Reginster; C Christiansen; B Dequinze; R Deroisy; U Gaspard; A N Taquet; P Franchimont
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

5.  Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction.

Authors:  I N Alecrin; J M Aldrighi; M A Caldas; O C E Gebara; N H M Lopes; J A F Ramires
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

6.  Minimal levels of serum estradiol prevent postmenopausal bone loss.

Authors:  J Y Reginster; N Sarlet; R Deroisy; A Albert; U Gaspard; P Franchimont
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

Review 7.  Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.

Authors:  J A Balfour; D McTavish
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.